社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
超群yibo
IP属地:未知
+关注
帖子 · 182
帖子 · 182
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
超群yibo
超群yibo
·
2021-12-20
3 months down the road to see delivery figure.
Nio Says ET5, Launched Saturday, Is Already Its Model With Highest Pre-Orders
U.S. listed Chinese electric vehicle maker Nio Inc’s recently-launched electric sedan ET5, which wou
Nio Says ET5, Launched Saturday, Is Already Its Model With Highest Pre-Orders
看
2,125
回复
2
点赞
1
编组 21备份 2
分享
举报
超群yibo
超群yibo
·
2021-12-15
Cargo more demand than passengers during pandemic. Sea freight charges sky rocketing with bottle neck & delays.
非常抱歉,此主贴已删除
看
3,334
回复
评论
点赞
1
编组 21备份 2
分享
举报
超群yibo
超群yibo
·
2021-12-04
Hope they can achieve dream target
非常抱歉,此主贴已删除
看
2,183
回复
1
点赞
4
编组 21备份 2
分享
举报
超群yibo
超群yibo
·
2021-10-04
Pre order starts now.
Merck shares rose 2.46% in premarket trading
Merck shares rose 2.46% in premarket trading. Soon after the promising data disclosed by Merck for
Merck shares rose 2.46% in premarket trading
看
2,646
回复
1
点赞
5
编组 21备份 2
分享
举报
超群yibo
超群yibo
·
2021-09-20
Still long way to get the no 2 spot in EV.
非常抱歉,此主贴已删除
看
1,310
回复
2
点赞
3
编组 21备份 2
分享
举报
超群yibo
超群yibo
·
2021-09-20
Short squeeze is not lasting lately as many will take profit.
非常抱歉,此主贴已删除
看
1,669
回复
评论
点赞
2
编组 21备份 2
分享
举报
超群yibo
超群yibo
·
2021-09-14
$LIPPO MALLS INDO RETAIL TRUST(D5IU.SI)$
But last 7 trading days total abt 50millions share traded.
看
1,976
回复
2
点赞
3
编组 21备份 2
分享
举报
超群yibo
超群yibo
·
2021-09-13
Need to fix requirements by HKSE first.
非常抱歉,此主贴已删除
看
1,307
回复
2
点赞
2
编组 21备份 2
分享
举报
超群yibo
超群yibo
·
2021-09-03
Pendemic create oppoturnity. Endemic creat revenue.
FDA Weighing Dose of Moderna Covid-19 Booster
Vaccine maker has asked agency to authorize booster at half the dose given in the first two shots.
FDA Weighing Dose of Moderna Covid-19 Booster
看
1,331
回复
2
点赞
3
编组 21备份 2
分享
举报
超群yibo
超群yibo
·
2021-09-03
Super Apps ambitious.
非常抱歉,此主贴已删除
看
1,827
回复
1
点赞
3
编组 21备份 2
分享
举报
加载更多
暂无关注
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"3576231291459124","uuid":"3576231291459124","gmtCreate":1613143162953,"gmtModify":1615904468341,"name":"超群yibo","pinyin":"cqyibochaoqunyibo","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":20,"headSize":234,"tweetSize":182,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":4,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"228c86a078844d74991fff2b7ab2428d-3","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资合伙人虎","description":"证券账户累计交易金额达到100万美元","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.93%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.06.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.29%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":693144259,"gmtCreate":1639992272896,"gmtModify":1639992273171,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"3 months down the road to see delivery figure.","listText":"3 months down the road to see delivery figure.","text":"3 months down the road to see delivery figure.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/693144259","repostId":"1126062795","repostType":2,"repost":{"id":"1126062795","kind":"news","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1639989019,"share":"https://www.laohu8.com/m/news/1126062795?lang=&edition=full","pubTime":"2021-12-20 16:30","market":"us","language":"en","title":"Nio Says ET5, Launched Saturday, Is Already Its Model With Highest Pre-Orders","url":"https://stock-news.laohu8.com/highlight/detail?id=1126062795","media":"Benzinga","summary":"U.S. listed Chinese electric vehicle maker Nio Inc’s recently-launched electric sedan ET5, which wou","content":"<p>U.S. listed Chinese electric vehicle maker <b>Nio Inc’s</b> recently-launched electric sedan ET5, which would compete with <b>Tesla Inc’s</b> <b>Model 3</b>, has become its most pre-ordered model, cnEVpost reported, citing the company CEO <b>William Li.</b></p>\n<p><b>What Happened:</b> The Shanghai, China-based Nio revealed the ET5 on Saturday at the company’s annual day and said its fifth production model was immediately available for pre-order.</p>\n<p>Customers rushed to pre-order the ET5 and some complained that the Nio app was experiencing network delays and had crashed, making it tougher for them to go ahead with the booking.</p>\n<p>In comparison, the rate of booking was much faster than the full-size ET7 sedan, which was launched in January, the report noted.</p>\n<p>Deliveries for the ET5 are scheduled to begin in September 2022 while for the ET7 it is not due until the end of the first quarter next year.</p>\n<p><b>Why It Matters:</b>The ET5 was revealed at the Nio Day event in Suzhou over the weekend. The all-electric sedan comes at a starting price of $51,500 (328,000 yuan) before government subsidies. Tesla’s best-selling Model 3 is priced at $40,905 onwards, after subsidies.</p>\n<p>Nio also announced plans to enter Germany, Netherlands, Denmark and Sweden in 2022, and reach 25 countries by 2025. The company stopped short of confirming an expansion into the U.S. market at the event.</p>\n<p><b>Price Action:</b>Nio shares closed 0.23% lower at $30 a share on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nio Says ET5, Launched Saturday, Is Already Its Model With Highest Pre-Orders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNio Says ET5, Launched Saturday, Is Already Its Model With Highest Pre-Orders\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-20 16:30</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. listed Chinese electric vehicle maker <b>Nio Inc’s</b> recently-launched electric sedan ET5, which would compete with <b>Tesla Inc’s</b> <b>Model 3</b>, has become its most pre-ordered model, cnEVpost reported, citing the company CEO <b>William Li.</b></p>\n<p><b>What Happened:</b> The Shanghai, China-based Nio revealed the ET5 on Saturday at the company’s annual day and said its fifth production model was immediately available for pre-order.</p>\n<p>Customers rushed to pre-order the ET5 and some complained that the Nio app was experiencing network delays and had crashed, making it tougher for them to go ahead with the booking.</p>\n<p>In comparison, the rate of booking was much faster than the full-size ET7 sedan, which was launched in January, the report noted.</p>\n<p>Deliveries for the ET5 are scheduled to begin in September 2022 while for the ET7 it is not due until the end of the first quarter next year.</p>\n<p><b>Why It Matters:</b>The ET5 was revealed at the Nio Day event in Suzhou over the weekend. The all-electric sedan comes at a starting price of $51,500 (328,000 yuan) before government subsidies. Tesla’s best-selling Model 3 is priced at $40,905 onwards, after subsidies.</p>\n<p>Nio also announced plans to enter Germany, Netherlands, Denmark and Sweden in 2022, and reach 25 countries by 2025. The company stopped short of confirming an expansion into the U.S. market at the event.</p>\n<p><b>Price Action:</b>Nio shares closed 0.23% lower at $30 a share on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NIO":"蔚来"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126062795","content_text":"U.S. listed Chinese electric vehicle maker Nio Inc’s recently-launched electric sedan ET5, which would compete with Tesla Inc’s Model 3, has become its most pre-ordered model, cnEVpost reported, citing the company CEO William Li.\nWhat Happened: The Shanghai, China-based Nio revealed the ET5 on Saturday at the company’s annual day and said its fifth production model was immediately available for pre-order.\nCustomers rushed to pre-order the ET5 and some complained that the Nio app was experiencing network delays and had crashed, making it tougher for them to go ahead with the booking.\nIn comparison, the rate of booking was much faster than the full-size ET7 sedan, which was launched in January, the report noted.\nDeliveries for the ET5 are scheduled to begin in September 2022 while for the ET7 it is not due until the end of the first quarter next year.\nWhy It Matters:The ET5 was revealed at the Nio Day event in Suzhou over the weekend. The all-electric sedan comes at a starting price of $51,500 (328,000 yuan) before government subsidies. Tesla’s best-selling Model 3 is priced at $40,905 onwards, after subsidies.\nNio also announced plans to enter Germany, Netherlands, Denmark and Sweden in 2022, and reach 25 countries by 2025. The company stopped short of confirming an expansion into the U.S. market at the event.\nPrice Action:Nio shares closed 0.23% lower at $30 a share on Friday.","news_type":1,"symbols_score_info":{"NIO":0.9}},"isVote":1,"tweetType":1,"viewCount":2125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607524882,"gmtCreate":1639567572878,"gmtModify":1639568148412,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"Cargo more demand than passengers during pandemic. Sea freight charges sky rocketing with bottle neck & delays.","listText":"Cargo more demand than passengers during pandemic. Sea freight charges sky rocketing with bottle neck & delays.","text":"Cargo more demand than passengers during pandemic. Sea freight charges sky rocketing with bottle neck & delays.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607524882","repostId":"1103453633","repostType":2,"isVote":1,"tweetType":1,"viewCount":3334,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608006676,"gmtCreate":1638578120397,"gmtModify":1638578120518,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"Hope they can achieve dream target","listText":"Hope they can achieve dream target","text":"Hope they can achieve dream target","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608006676","repostId":"2188291505","repostType":4,"isVote":1,"tweetType":1,"viewCount":2183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":820918014,"gmtCreate":1633339338668,"gmtModify":1633339339052,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"Pre order starts now.","listText":"Pre order starts now.","text":"Pre order starts now.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/820918014","repostId":"1175650769","repostType":4,"repost":{"id":"1175650769","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1633334498,"share":"https://www.laohu8.com/m/news/1175650769?lang=&edition=full","pubTime":"2021-10-04 16:01","market":"us","language":"en","title":"Merck shares rose 2.46% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1175650769","media":"Tiger Newspress","summary":"Merck shares rose 2.46% in premarket trading.\n\nSoon after the promising data disclosed by Merck for ","content":"<p>Merck shares rose 2.46% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/eaf5c73e80e8f49f4dc85e7540e3096d\" tg-width=\"876\" tg-height=\"580\" referrerpolicy=\"no-referrer\"></p>\n<p>Soon after the promising data disclosed by Merck for its COVID-19 pill, being developed in partnership with Ridgeback Biotherapeutics, countries, including the U.K. and Malaysia, have shown willingness to procure the experimental antiviral drug.</p>\n<p>An effective, convenient oral COVID-19 treatment could generate over $10 billion of annual sales, <i>Reuters</i> reported citing estimates from Jefferies.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck shares rose 2.46% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck shares rose 2.46% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-10-04 16:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Merck shares rose 2.46% in premarket trading.</p>\n<p><img src=\"https://static.tigerbbs.com/eaf5c73e80e8f49f4dc85e7540e3096d\" tg-width=\"876\" tg-height=\"580\" referrerpolicy=\"no-referrer\"></p>\n<p>Soon after the promising data disclosed by Merck for its COVID-19 pill, being developed in partnership with Ridgeback Biotherapeutics, countries, including the U.K. and Malaysia, have shown willingness to procure the experimental antiviral drug.</p>\n<p>An effective, convenient oral COVID-19 treatment could generate over $10 billion of annual sales, <i>Reuters</i> reported citing estimates from Jefferies.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175650769","content_text":"Merck shares rose 2.46% in premarket trading.\n\nSoon after the promising data disclosed by Merck for its COVID-19 pill, being developed in partnership with Ridgeback Biotherapeutics, countries, including the U.K. and Malaysia, have shown willingness to procure the experimental antiviral drug.\nAn effective, convenient oral COVID-19 treatment could generate over $10 billion of annual sales, Reuters reported citing estimates from Jefferies.","news_type":1,"symbols_score_info":{"MRK":0.9}},"isVote":1,"tweetType":1,"viewCount":2646,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":887754054,"gmtCreate":1632102146178,"gmtModify":1632802840485,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"Still long way to get the no 2 spot in EV.","listText":"Still long way to get the no 2 spot in EV.","text":"Still long way to get the no 2 spot in EV.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/887754054","repostId":"1165266849","repostType":2,"isVote":1,"tweetType":1,"viewCount":1310,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":887751250,"gmtCreate":1632101913370,"gmtModify":1632802844120,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"Short squeeze is not lasting lately as many will take profit.","listText":"Short squeeze is not lasting lately as many will take profit.","text":"Short squeeze is not lasting lately as many will take profit.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/887751250","repostId":"1163337358","repostType":2,"isVote":1,"tweetType":1,"viewCount":1669,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":886572063,"gmtCreate":1631610417952,"gmtModify":1631888847697,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/D5IU.SI\">$LIPPO MALLS INDO RETAIL TRUST(D5IU.SI)$</a>But last 7 trading days total abt 50millions share traded.","listText":"<a href=\"https://laohu8.com/S/D5IU.SI\">$LIPPO MALLS INDO RETAIL TRUST(D5IU.SI)$</a>But last 7 trading days total abt 50millions share traded.","text":"$LIPPO MALLS INDO RETAIL TRUST(D5IU.SI)$But last 7 trading days total abt 50millions share traded.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/886572063","isVote":1,"tweetType":1,"viewCount":1976,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":888288668,"gmtCreate":1631499311354,"gmtModify":1631889976198,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"Need to fix requirements by HKSE first.","listText":"Need to fix requirements by HKSE first.","text":"Need to fix requirements by HKSE first.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/888288668","repostId":"2166348780","repostType":4,"isVote":1,"tweetType":1,"viewCount":1307,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815328317,"gmtCreate":1630646984939,"gmtModify":1631889976203,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"Pendemic create oppoturnity. Endemic creat revenue.","listText":"Pendemic create oppoturnity. Endemic creat revenue.","text":"Pendemic create oppoturnity. Endemic creat revenue.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/815328317","repostId":"1194913620","repostType":4,"repost":{"id":"1194913620","kind":"news","pubTimestamp":1630637588,"share":"https://www.laohu8.com/m/news/1194913620?lang=&edition=full","pubTime":"2021-09-03 10:53","market":"us","language":"en","title":"FDA Weighing Dose of Moderna Covid-19 Booster","url":"https://stock-news.laohu8.com/highlight/detail?id=1194913620","media":"The Wall Street Journal","summary":"Vaccine maker has asked agency to authorize booster at half the dose given in the first two shots.\n\n","content":"<blockquote>\n <b>Vaccine maker has asked agency to authorize booster at half the dose given in the first two shots.</b>\n</blockquote>\n<p>The Food and Drug Administration is considering whether to authorize a lower dose ofModernaInc.’sCovid-19 vaccine for boostersthan the dose given in the first two shots, people familiar with the deliberations said.</p>\n<p>Moderna said Wednesday it is asking the FDA to authorize a 50 microgram dose, half the dosage of the first two shots. Some in the government are leaning toward authorizing the 100 microgram dose, the people said, because of concerns a lower-dose booster might not offer a durable enough boost to counterfast-changing variants of Covid-19.</p>\n<p>No final decision has been made, the people said, as the FDA is still reviewing data from studies that tested boosters using the different doses. People who have seen the data said both doses produce a strong immune response.</p>\n<p>Complicating the decision is the fact that the FDA has limited comparative data on which to base their choice, one person familiar with the discussions said.</p>\n<p>The continuing deliberations are a reason the agency hasn’t yet authorized boosters, though the people expect a decision soon.</p>\n<p>One possible benefit of a lower dose is fewer side effects, people familiar with the matter said.</p>\n<p>Last month, the Biden administration recommended that adults who got a messenger RNA vaccine from either Moderna orPfizerInc.and partnerBioNTech SEstartgetting boosters this month.</p>\n<p>Johnson & Johnson’svaccine is also expected to be included in the boosting strategy,after releasing the first resultsabout its boosters last month. The company said it is engaging with the FDA.</p>\n<p>There is no debate about the booster doses to administer for the Pfizer-BioNTech or J&J vaccines, one of the people said, though a decision on the J&J booster might take longer. Their boosters will be the same doses as the first shots, the person said.</p>\n<p>After initially spurning talk about boosters, federal health officials embraced the idea as the contagious Delta variant drove up case counts, even among some peoplewho were vaccinated.</p>\n<p>Also contributing to the change of mind was emerging but inconclusive evidence, from researchers in Israel and elsewhere, suggesting the molecular defenses triggered by vaccinationwanes after several months.</p>\n<p>Whether boosters are needed remains up for debate. Some researchers say the evidence is insufficient, while the World Health Organization has urged giving shots to peoplein countries with limited supplies.</p>\n<p>Moderna and the National Institutes of Health tested both 50 mcg and 100 mcg booster doses in clinical trials.</p>\n<p>Last month, Modernareleased initial datashowing that a 50 mcg booster strengthened antibodies against Delta and other variants of concern significantly higher than the levels after trial subjects received their two initial doses.</p>\n<p>The Cambridge, Mass., company has been urging the FDA in recent weeks to authorize a 50 mcg booster, according to people familiar with the matter and a statement announcing its submission on Wednesday.</p>\n<p>The company declined to answer questions early this week about its talks with the FDA, before issuing a statement, saying it had applied for the booster dose authorization at the 50 mcg level.</p>\n<p>Authorization of a lower dose would allow Moderna to manufacture up to three billion boosters next year, as many as one billion more than it could make of the higher dose.</p>\n<p>Yet it would pose several logistical challenges, another person familiar with the discussions said.</p>\n<p>The different dosages may cause confusion at vaccination sites, the people said. Pharmacists would have to prepare the doses in different ways. Nurses would have to be careful to give people the right dose.</p>\n<p>Another issue, the person said, is a lower dose would lead to some wasted vaccine, at least until new, smaller vials begin arriving in October.</p>\n<p>Current Moderna vials contain enough vaccine for 14 100 mcg doses, but not all of that could be used for smaller doses because the vials can only be entered a certain number of times.</p>\n<p>The U.S. has ordered smaller vials already because they are easier for doctors’ offices and other providers to administer, the person said.</p>\n<p>It couldn’t be determined why people getting a Moderna booster might need a lower dose than people getting another manufacturer’s vaccine.</p>\n<p>Astudy of Belgian healthcare workerspublished Monday in a letter to the Journal of American Medical Association found that Moderna’s vaccine created twice as many antibodies as the Pfizer-BioNTech vaccine.</p>\n<p>The researchers said the difference might be explained by the higher mRNA content in Moderna’s vaccine as compared with Pfizer-BioNTech’s, as well as the week longer interval between shots for the Moderna vaccine.</p>\n<p>U.S. health officials are still figuring out the timing of exactly when people will be eligible to receive boosters.</p>\n<p>Federal health officials initially said it would be eight months after people have received two doses. The Wall Street Journal has reported the FDA is likelyto authorize boosters at six months.</p>\n<p>President Biden said last week that his administration is weighing whether to begin before eight months, perhaps as early as five months.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>FDA Weighing Dose of Moderna Covid-19 Booster</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFDA Weighing Dose of Moderna Covid-19 Booster\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-03 10:53 GMT+8 <a href=https://www.wsj.com/articles/fda-weighing-dose-of-moderna-covid-19-booster-11630593980?mod=business_lead_pos5><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Vaccine maker has asked agency to authorize booster at half the dose given in the first two shots.\n\nThe Food and Drug Administration is considering whether to authorize a lower dose ofModernaInc.’...</p>\n\n<a href=\"https://www.wsj.com/articles/fda-weighing-dose-of-moderna-covid-19-booster-11630593980?mod=business_lead_pos5\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.wsj.com/articles/fda-weighing-dose-of-moderna-covid-19-booster-11630593980?mod=business_lead_pos5","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1194913620","content_text":"Vaccine maker has asked agency to authorize booster at half the dose given in the first two shots.\n\nThe Food and Drug Administration is considering whether to authorize a lower dose ofModernaInc.’sCovid-19 vaccine for boostersthan the dose given in the first two shots, people familiar with the deliberations said.\nModerna said Wednesday it is asking the FDA to authorize a 50 microgram dose, half the dosage of the first two shots. Some in the government are leaning toward authorizing the 100 microgram dose, the people said, because of concerns a lower-dose booster might not offer a durable enough boost to counterfast-changing variants of Covid-19.\nNo final decision has been made, the people said, as the FDA is still reviewing data from studies that tested boosters using the different doses. People who have seen the data said both doses produce a strong immune response.\nComplicating the decision is the fact that the FDA has limited comparative data on which to base their choice, one person familiar with the discussions said.\nThe continuing deliberations are a reason the agency hasn’t yet authorized boosters, though the people expect a decision soon.\nOne possible benefit of a lower dose is fewer side effects, people familiar with the matter said.\nLast month, the Biden administration recommended that adults who got a messenger RNA vaccine from either Moderna orPfizerInc.and partnerBioNTech SEstartgetting boosters this month.\nJohnson & Johnson’svaccine is also expected to be included in the boosting strategy,after releasing the first resultsabout its boosters last month. The company said it is engaging with the FDA.\nThere is no debate about the booster doses to administer for the Pfizer-BioNTech or J&J vaccines, one of the people said, though a decision on the J&J booster might take longer. Their boosters will be the same doses as the first shots, the person said.\nAfter initially spurning talk about boosters, federal health officials embraced the idea as the contagious Delta variant drove up case counts, even among some peoplewho were vaccinated.\nAlso contributing to the change of mind was emerging but inconclusive evidence, from researchers in Israel and elsewhere, suggesting the molecular defenses triggered by vaccinationwanes after several months.\nWhether boosters are needed remains up for debate. Some researchers say the evidence is insufficient, while the World Health Organization has urged giving shots to peoplein countries with limited supplies.\nModerna and the National Institutes of Health tested both 50 mcg and 100 mcg booster doses in clinical trials.\nLast month, Modernareleased initial datashowing that a 50 mcg booster strengthened antibodies against Delta and other variants of concern significantly higher than the levels after trial subjects received their two initial doses.\nThe Cambridge, Mass., company has been urging the FDA in recent weeks to authorize a 50 mcg booster, according to people familiar with the matter and a statement announcing its submission on Wednesday.\nThe company declined to answer questions early this week about its talks with the FDA, before issuing a statement, saying it had applied for the booster dose authorization at the 50 mcg level.\nAuthorization of a lower dose would allow Moderna to manufacture up to three billion boosters next year, as many as one billion more than it could make of the higher dose.\nYet it would pose several logistical challenges, another person familiar with the discussions said.\nThe different dosages may cause confusion at vaccination sites, the people said. Pharmacists would have to prepare the doses in different ways. Nurses would have to be careful to give people the right dose.\nAnother issue, the person said, is a lower dose would lead to some wasted vaccine, at least until new, smaller vials begin arriving in October.\nCurrent Moderna vials contain enough vaccine for 14 100 mcg doses, but not all of that could be used for smaller doses because the vials can only be entered a certain number of times.\nThe U.S. has ordered smaller vials already because they are easier for doctors’ offices and other providers to administer, the person said.\nIt couldn’t be determined why people getting a Moderna booster might need a lower dose than people getting another manufacturer’s vaccine.\nAstudy of Belgian healthcare workerspublished Monday in a letter to the Journal of American Medical Association found that Moderna’s vaccine created twice as many antibodies as the Pfizer-BioNTech vaccine.\nThe researchers said the difference might be explained by the higher mRNA content in Moderna’s vaccine as compared with Pfizer-BioNTech’s, as well as the week longer interval between shots for the Moderna vaccine.\nU.S. health officials are still figuring out the timing of exactly when people will be eligible to receive boosters.\nFederal health officials initially said it would be eight months after people have received two doses. The Wall Street Journal has reported the FDA is likelyto authorize boosters at six months.\nPresident Biden said last week that his administration is weighing whether to begin before eight months, perhaps as early as five months.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":815323715,"gmtCreate":1630646838837,"gmtModify":1631889976202,"author":{"id":"3576231291459124","authorId":"3576231291459124","name":"超群yibo","avatar":"https://static.tigerbbs.com/6594cf6901beda8fdf0f00a0e5853f18","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576231291459124","authorIdStr":"3576231291459124"},"themes":[],"htmlText":"Super Apps ambitious.","listText":"Super Apps ambitious.","text":"Super Apps ambitious.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/815323715","repostId":"1137593739","repostType":4,"isVote":1,"tweetType":1,"viewCount":1827,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"following","isTTM":false}